Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial
Robert E. Coleman(Weston Park Cancer Centre), David Cameron(Edinburgh Cancer Research), David Dodwell(University of Leeds), Richard H. Bell, Caroline Wilson(University of Sheffield), Emma Rathbone(St James's University Hospital), Maccon Keane(University Hospital Galway), Miguel Gil‐Gil(Institut Català d'Oncologia), Roger Burkinshaw(University of Sheffield), Robert Grieve(University Hospitals Coventry and Warwickshire NHS Trust), Peter Barrett‐Lee(Velindre Cancer Centre), Diana Ritchie(Beatson West of Scotland Cancer Centre), Victoria Liversedge(University of Leeds), Samantha Hinsley(University of Leeds), Helen Marshall(University of Leeds)
Cited by 293
Abstract
Related Papers
No related papers found
Powered by citation graph analysis